期刊文献+

肺癌细胞株EGFR和MRP基因mRNA表达相关性研究 被引量:1

The Expression Relationship Study of EGFR and MRP Gene mRNA in Lung Cancer Cell Line
下载PDF
导出
摘要 目的研究肺癌细胞株表皮生长因子受体基因 (EGFRgene)mRNA与多药耐药性相关蛋白基因—MRP基因 (MRPgene)mRNA表达相关性。  方法原位分子杂交技术检测耐药性 /非耐药性肺癌细胞株EGFR、MRP基因mRNA表达。 结果耐药性 /非耐药性肺癌细胞株均有不同程度EGFR、MRP基因mRNA表达 ,其表达与肺癌细胞株耐药性相关 ,且EGFR和MRP基因mRNA表达有明显相关性。 结论EGFR基因与MRP基因密切相关并影响肺癌细胞耐药性。 Objective To explore the expression relationship between epidermal growth factor receptor gene (EGFR gene) mRNA and multi-drug resistance associated protein gene (MRP gene) mR NA in the lung cancer cell lines. Methods The expression of EGFR and MRP gene mRNA in drug resistance/non-drug resistance lung cancer cell lines were determined by in situ hybridization. Results Drug resistance/non-drug resistance lung cancer cell lines were found to have expression of EGFR and MRP gene mRNA, the expression level was relatively and nearly related with drug resistance, and the expression of EGFR, MRP gene mRNA had relationship obviously. Conclusion EGFR gene had relationship with MRP gene and is related with drug resistance in lung cancer.
出处 《上海第二医科大学学报》 CSCD 2001年第4期310-312,共3页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 肺癌细胞株 EGFR基因 MRP基因 肺癌 MRNA lung cancer cell line EGFR gene MRP gene relationship
  • 相关文献

参考文献4

二级参考文献2

共引文献12

同被引文献30

  • 1Swannie HC, Kaye SB. Protein kinase C inhibitors. Curr Oncol Rep,2002,4(1):37-46.
  • 2Sonnemann J, Gekeler V, Ahlbrecht K, et al. Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel. Cancer Lett,2004,209(2):177-185.
  • 3Clark AS, West KA, Blumberg PM, et al. Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. Cancer Res,2003,63(4):780-786.
  • 4Ding L, Wang H, Lang W, et al. Protein kinase C-epsilon promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway. J Biol Chem,2002,277(38):35305-35313.
  • 5Yuen AR, Halsey J, Fisher GA, et al. Phase Ⅰ study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer. Clin Cancer Res,1999,5(11):3357-3363.
  • 6Jansen B, Zangemeister-Wittke U. Antisense therapy for cancer-the time of truth. Lancet Oncol,2002,3(11):672-683.
  • 7Hideshima T, Nakamura N, Chauhan D, et al. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene,2001,20(42):5991-6000.
  • 8Krystal GW, Sulanke G, Litz J. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Mol Cancer Ther,2002,1(11):913-922.
  • 9Lee SH, Kim HS, Park WS, et al. Non-small cell lung cancers frequently express phosphorylated Akt; an immunohistoche-mical study. APMIS,2002,110(7-8):587-592.
  • 10Brognard J, Clark AS, Ni Y, et al. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res,2001,61(10):3986-3997.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部